Biotech - A Framework for Disclosure
- Topics:
- Pharmeceuticals
- Tags:
- ASX,
- Biotechnology
- Source:
- Allens Arthur Robinson
FREE Registration is required
Overview: The ASX has recently drafted the "Code of Best Practice for Reporting by Biotechnology, Medical Device and other Life Sciences Companies" to govern biotechnology reporting methods. In this brief article, Lawyer Mark Malinas provides an overview of the proposed framework and describes the impacts of this framework on listed Biotechnology companies.
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: HTML | Date: Jun 2004 | Pages: 7



